FDA accepts IND for phase I/II study of Inovio's INO-3107 for recurrent respiratory papillomatosis Feb. 11, 2020 No Comments
Hoth Therapeutics begins preclinical gene therapy study for asthma and allergic inflammation Feb. 5, 2020 No Comments
New CRLF2 ligands identified at Korea University Research and Business Foundation Jan. 28, 2020 No Comments
Redx Pharma nominates ROCK2 inhibitor RXC-007 as drug development candidate in fibrosis Jan. 10, 2020 No Comments